Search Results

Displaying Results 1-1 of 1 "'LVTX'"

Oct 20, 2025, 12:58 ET Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement

MILWAUKEE, Oct. 20, 2025 /PRNewswire/ --The Ademi Firm is investigating Lava (Nasdaq: LVTX) for possible breaches of fiduciary duty and other violations of law in its transaction with XOMA Royalty.

More news about: Ademi LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.